Chris Walsh

Chris Walsh is an experienced attorney who currently serves as General Counsel at Denali Therapeutics. Prior to joining Denali, Chris spent eight years at Genentech where they served as Assistant General Counsel and Practice Group Leader. Chris has also worked at Sterne, Kessler, Goldstein & Fox and McAndrews, Held & Malloy, Ltd.

Chris Walsh received a B.S. in Chemistry from Illinois State University, a Ph.D. in Chemistry from the Illinois Institute of Technology, and a J.D. from The George Washington University Law School. Chris also did postdoctoral research in organic chemistry at Northwestern University.

Chris Walsh works with Wei Dong - VP, Drug Safety, Dana Andersen - Chief Technical & Manufacturing Officer, and Michael Ostland - VP, Development - Europe. Chris Walsh reports to Ryan Watts, CEO.